Blood sugar control and a diabetes drug on insulin production
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study looks at how blood sugar control and a class of drugs called GLP-1 agonists (like Ozempic) affect insulin-making cells in people with type 1 or type 2 diabetes who use insulin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 1 or type 2 diabetes and take insulin
- You are between 25 and 70 years old
- Your recent blood sugar test (A1C) is 10.0% or lower
- You have not taken a GLP-1 drug (like Ozempic, Trulicity, or Byetta) in the past year
- You have not had upper abdominal surgery (like gastric banding or stomach bypass)
- You do not have a serious illness, cancer, or complications from diabetes (like heart or kidney disease)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a GLP-1 receptor agonist (a type of medicine that helps control blood sugar and appetite) can improve metabolic health in people with early type 1 diabetes. It may be an option if you have already taken teplizumab to delay the disease or were recently diagnosed with type 1 diabetes.
This study tests whether adding the diabetes pill empagliflozin (Jardiance) to your current automated insulin pump can help improve blood sugar control for adults with type 1 diabetes who are not reaching their glucose goals.
This trial tests a medicine called a GLP-1 receptor agonist (like Ozempic) to see if it can help people with very early type 1 diabetes (stage 1) keep their insulin-making cells working longer. You may be a good fit if you have stage 1 type 1 diabetes and haven't needed insulin yet.
This study tests if a type 2 diabetes medication called a GLP-1 receptor agonist (like Ozempic) is safe and effective for people on dialysis. It may help manage blood sugar and improve health outcomes for those with kidney failure.
This trial compares two treatment approaches—liraglutide injections versus a specific insulin (glargine) injection—plus meal-time insulin dosing (“bolus”) in adults with overweight/obesity and type 2 diabetes that isn’t well controlled. The goal is to see which option works better and is safer for improving blood sugar.
This Phase 4 study looks at how to help women with a recent history of gestational diabetes get their blood sugar back toward normal levels. It likely includes blood-sugar testing and a controlled diet period to see what works best.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.